Bp PLC Regeneron Pharmaceuticals, Inc. Transaction History

Bp PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $1.39 Million - $1.65 Million	-2,429 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $481,310 - $568,593	-1,018 Reduced 29.53%	2,429 $1.36 Million
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $402,057 - $493,380	-900 Reduced 20.7%	3,447 $1.63 Million
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $1.94 Million - $2.46 Million	-4,053 Reduced 48.25%	4,347 $2.1 Million
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $381,325 - $460,747	-700 Reduced 7.69%	8,400 $4.7 Million
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $542,652 - $708,312	1,100 Added 13.75%	9,100 $5.67 Million
Q2 2019 Jul 29, 2019	SELL	$299.6 - $414.82 $179,760 - $248,892	-600 Reduced 6.98%	8,000 $2.5 Million
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $470,148 - $564,256	-1,400 Reduced 14.0%	8,600 $3.21 Million
Q3 2018 Nov 02, 2018	BUY	$351.14 - $408.51 $351,140 - $408,510	1,000 Added 11.11%	10,000 $4.04 Million
Q4 2017 Feb 06, 2018	SELL	$358.63 - $469.95 $358,630 - $469,950	-1,000 Reduced 10.0%	9,000 $3.38 Million
Q3 2017 Oct 30, 2017	BUY	$431.38 - $504.0 $4.31 Million - $5.04 Million	10,000	10,000 $4.47 Million

1,464

84.4M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $109B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.